Literature DB >> 14111744

HYPERTENSION DUE TO RENAL ARTERY OCCLUSION SIMULATING PRIMARY ALDOSTERONISM.

J C LAIDLAW, E R YENDT, C E BIRD, A G GORNALL.   

Abstract

Entities:  

Keywords:  ALDOSTERONE; ANGIOTENSIN; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; HYPERALDOSTERONISM; HYPERTENSION, RENAL; POTASSIUM; PROGESTERONE; RENAL ARTERY OBSTRUCTION; RENIN; SODIUM; SPIRONOLACTONE

Mesh：

Substances：

Year:  1964        PMID： 14111744      PMCID： PMC1922465     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  STUDY OF ADRENOCORTICAL FUNCTION IN OBESITY.

Authors:  C J MIGEON; O C GREEN; J P ECKERT
Journal:  Metabolism       Date:  1963-08       Impact factor: 8.694

2.  Aldosteronism in man. Some clinical and climatological aspects. II.

Authors:  J W CONN
Journal:  JAMA       Date:  1963-03-09       Impact factor: 56.272

3.  Hyperaldosteronism secondary to renal ischaemia.

Authors:  A H GOWENLOCK; O WRONG
Journal:  Q J Med       Date:  1962-07

4.  The diagnosis and treatment of renal hypertension; with special reference to a case of hypertension due to stenosis of both renal arteries.

Authors:  E R YENDT; W K KERR; D R WILSON; Z F JAWORSKI
Journal:  Am J Med       Date:  1960-02       Impact factor: 4.965

5.  The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man.

Authors:  S ULICK; J H LARAGH; S LIEBERMAN
Journal:  Trans Assoc Am Physicians       Date:  1958

6.  Effect of heparinoid and spirolactone on the renal excretion of sodium and aldosterone.

Authors:  V CEJKA; L de VRIES; J van DAATSELAAR; J G BORST; C L MAJOOR
Journal:  Lancet       Date:  1960-02-06       Impact factor: 79.321

7.  Hypertension caused by renal artery occlusion simulating primary aldosteronism.

Authors:  J C LAIDLAW; E R YENDT; A G GORNALL
Journal:  Metabolism       Date:  1960-07       Impact factor: 8.694

8.  Aldosterone secretion and primary and malignant hypertension.

Authors:  J H LARAGH; S ULICK; V JANUSZEWICZ; Q B DEMING; W G KELLY; S LIEBERMAN
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

9.  Effects of a spirolactone (SC-8109) in primary mineralocorticoid excess.

Authors:  H KISTLER; T F FRAWLEY
Journal:  J Clin Endocrinol Metab       Date:  1960-08       Impact factor: 5.958

10.  The influence of estrogen and progesterone on aldosterone excretion.

Authors:  J C LAIDLAW; J L RUSE; A G GORNALL
Journal:  J Clin Endocrinol Metab       Date:  1962-02       Impact factor: 5.958
View more
  6 in total

1.  SYNDROMES OF RENAL-ARTERY STENOSIS.

Authors:  J DRAEGER
Journal:  Br Med J       Date:  1965-04-10

Review 2.  [Hypermineralocorticoidism and hypertension].

Authors:  H P Wolff; S Abdelhamid
Journal:  Klin Wochenschr       Date:  1971-03-15

Review 3.  The adrenal cortex in internal medicine. II.

Authors:  C L Cope
Journal:  Br Med J       Date:  1966-10-15

4.  [Aldosterone metabolism in renal artery stenosis].

Authors:  W Kaufmann; B Steiner; F Dürr; H Nieth; C Behn
Journal:  Klin Wochenschr       Date:  1967-10-01

5.  Plasma renin and hypertension.

Authors: 
Journal:  Br Med J       Date:  1966-02-26

6.  Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.

Authors:  D J Sutherland; J L Ruse; J C Laidlaw
Journal:  Can Med Assoc J       Date:  1966-11-26       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.